S2392 — Authorizes medical cannabis for treatment of sickle cell anemia.

S2392 — Authorizes medical cannabis for treatment of sickle cell anemia. · Informed CitizenryThis bill amends existing New Jersey law to include sickle cell anemia as a qualifying medical condition for the use of medical cannabis. It updates the definition of 'qualifying medical condition'…Open in Informed Citizenry